Jackson Square Partners LLC 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 06:42 am Sale | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Jackson Square Partners LLC | 9,704,766 3.630% | -5,300,411 (-35.32%) | Filing |
| 2023-02-09 7:12 pm Sale | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Jackson Square Partners LLC | 15,005,177 6.640% | -7,418,738 (-33.08%) | Filing |
| 2022-02-04 8:55 pm Purchase | 2022-01-31 | 13G | Pacific Biosciences of California, Inc. PACB | Jackson Square Partners LLC | 22,423,915 10.170% | 8,949,477 (+66.42%) | Filing |
| 2021-02-09 2:10 pm Purchase | 2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Jackson Square Partners LLC | 13,474,438 7.240% | 13,474,438 (New Position) | Filing |